These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 35093510)

  • 21. A comparative analysis of clinical characteristics in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) between Wuhan and Zhoushan, China.
    Li H; Li L; Zheng H; Xiao M; Wang Q; Li S; Zhu W
    Ann Palliat Med; 2021 Dec; 10(12):12810-12820. PubMed ID: 35016431
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Chaikul P; Kanlayavattanakul M; Somkumnerd J; Lourith N
    J Tradit Complement Med; 2021 Sep; 11(5):390-399. PubMed ID: 34522633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant, anti-collagenase and anti-elastase activities of Phyllanthus emblica, Manilkara zapota and silymarin: an in vitro comparative study for anti-aging applications.
    Pientaweeratch S; Panapisal V; Tansirikongkol A
    Pharm Biol; 2016 Sep; 54(9):1865-72. PubMed ID: 26912420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process.
    Yokozawa T; Kim HY; Kim HJ; Okubo T; Chu DC; Juneja LR
    Br J Nutr; 2007 Jun; 97(6):1187-95. PubMed ID: 17506915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of epidemiology, clinical features, prognosis, diagnosis and treatment outcomes of patients with COVID-19 in West Azerbaijan Province.
    Gharebaghi N; Farshid S; Boroofeh B; Nejadrahim R; Mousavi J; Dindarian S; Mohammadi S
    Int J Clin Pract; 2021 Jun; 75(6):e14108. PubMed ID: 33626210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review.
    Latarissa IR; Meiliana A; Sormin IP; Sugiono E; Wathoni N; Barliana MI; Lestari K
    Front Pharmacol; 2024; 15():1383359. PubMed ID: 38873430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial.
    Akbari N; Ostadrahimi A; Tutunchi H; Pourmoradian S; Farrin N; Najafipour F; Soleimanzadeh H; Kafil B; Mobasseri M
    J Trace Elem Med Biol; 2022 May; 71():126945. PubMed ID: 35183882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Persian barley water on clinical outcomes of hospitalized moderate-severity COVID-19 patients: a single-blind, add-on therapy, randomized controlled clinical trial.
    Tavakoli A; Molavi Vardanjani H; Namjouyan F; Cramer H; Pasalar M
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1033-1041. PubMed ID: 35179770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome of
    Mahajan S; Bisht MS; Chakraborty A; Sharma VK
    Front Plant Sci; 2023; 14():1210078. PubMed ID: 37727852
    [No Abstract]   [Full Text] [Related]  

  • 30. Computational and network pharmacology studies of
    Chikhale RV; Sinha SK; Khanal P; Gurav NS; Ayyanar M; Prasad SK; Wanjari MM; Patil RB; Gurav SS
    Phytomed Plus; 2021 Aug; 1(3):100095. PubMed ID: 35399824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and Nutraceutical Significance of Amla (
    Gul M; Liu ZW; Iahtisham-Ul-Haq ; Rabail R; Faheem F; Walayat N; Nawaz A; Shabbir MA; Munekata PES; Lorenzo JM; Aadil RM
    Antioxidants (Basel); 2022 Apr; 11(5):. PubMed ID: 35624683
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of Plasmapheresis Treatment in the Treatment of Patients with COVID-19 Disease.
    Khodakarim N; Kalantari S; Riahi T; Moradians V; Talebi-Taher M; Yassin Z; Afshar H; Kooranifar S; Aloosh O; Ziaie S; Zamani N; Tirkan A; Ramim T
    Med J Islam Repub Iran; 2022; 36():83. PubMed ID: 36128282
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety of polyherbal formulation as an add-on to standard-of-care in mild-to-moderate COVID-19: A randomized, double-blind, placebo-controlled trial.
    Patankar SB; Gorde A; Joshi K; Suryawanshi K; Soni P; Shah T; Patankar S; Jha D; Raje R; Rangnekar H
    J Ayurveda Integr Med; 2022; 13(4):100653. PubMed ID: 36311474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Photobiomodulation Therapy on Lung Function and Inflammatory Factors in Patients with COVID-19 During Acute Stage.
    Ehsani F; Bagheri R; Darban M; Hemati M; Bahrami M; Sharafieh F
    Photobiomodul Photomed Laser Surg; 2023 Sep; 41(9):483-489. PubMed ID: 37738370
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of topical galbanum oil with dry cupping in hospitalized COVID-19 patients: A randomized open-label clinical trial.
    Seydi F; Salehi M; Hashem-Dabaghian F; Emadi F; Gholami-Fesharaki M; Iranzadasl M
    Avicenna J Phytomed; 2023; 13(4):388-399. PubMed ID: 37663385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of berberine pellet effect on clinical recovery time in COVID-19 outpatients: A pilot clinical trial.
    Omidvar Tehrani S; Ghasemzadeh Rahbardar M; Shoorgashti K; Dehghan Nayeri MJ; Mohammadpour AH; Hosseinzadeh H
    Avicenna J Phytomed; 2023; 13(3):265-279. PubMed ID: 37654997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double lucky? ASGE presidency during the early days of COVID-19.
    Mergener K
    Gastrointest Endosc; 2022 Apr; 95(4):790-792. PubMed ID: 35120734
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials.
    Setayesh L; Haghighat N; Rasaei N; Rezaei M; Casazza K; Nadery M; Yamrali I; Zamani M; Asbaghi O
    Diabetes Metab Syndr; 2023 Mar; 17(3):102729. PubMed ID: 36934568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of an oral product containing Amla fruit (Phyllanthus emblica L.) on female androgenetic alopecia: A randomized controlled trial.
    Akhbari M; Firooz A; Rahimi R; Shirzad M; Esmaealzadeh N; Shirbeigi L
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116958. PubMed ID: 37487962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical effects of Emblica officinalis fruit consumption on cardiovascular disease risk factors: a systematic review and meta-analysis.
    Brown PDS; Ketter N; Vis-Dunbar M; Sakakibara BM
    BMC Complement Med Ther; 2023 Jun; 23(1):190. PubMed ID: 37296402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.